IL-13 inhibitor monoclonal antibody

This page covers all IL-13 inhibitor monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-13.

Targets

IL-13

Phase 3 pipeline (1)

• GSK1358820 · GlaxoSmithKline · Immunology / Respiratory
  GSK1358820 is a monoclonal antibody that targets and inhibits IL-13, a key cytokine involved in type 2 inflammatory responses.

Patent intelligence

• il 13 inhibitor monoclonal antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates